Spacer
Spacer
SEARCH
Spacer
Spacer
Quotes News NAV
Spacer
Spacer
Spacer
Spacer
Spacer
Profit & Loss Markets  >  Corporate Information  >   Profit & Loss
Spacer
Aurobindo Pharma Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524804 INE406A01037 406.2420157 AUROPHARMA 0.22 103,395.41 37.63 47.76 1
Your Result on : Markets | Equity | Corporate Information | Profit & Loss
     ParticularsMar 2026
(Rs.Cr)
Mar 2025
(Rs.Cr)
Mar 2024
(Rs.Cr)
Mar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
INCOME :      
Sales Turnover 11171.7210933.3010645.648457.0011287.1415823.68
Excise Duty0.000.000.000.000.000.00
Net Sales11171.7210933.3010645.648457.0011287.1415823.68
Other Income 587.53328.12670.10443.92670.99589.86
Stock Adjustments -46.5567.66116.23263.95-45.51-2.99
Total Income11712.7011329.0811431.979164.8711912.6216410.55
EXPENDITURE :      
Raw Materials 5311.585675.345964.484755.955800.747241.83
Power & Fuel Cost174.82185.59191.58167.86477.99512.34
Employee Cost 1161.151063.07980.56890.531600.041735.42
Other Manufacturing Expenses 421.52426.63414.51328.42705.68925.86
Selling & Administrative Expenses 873.42960.27822.21939.381009.361069.84
Miscellaneous Expenses 108.12132.49164.49148.96249.13215.57
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure8050.618443.398537.837231.109842.9411700.86
Operating Profit3662.092885.692894.141933.772069.684709.69
Interest 213.15230.04182.6074.5816.9428.68
Gross Profit3448.942655.652711.541859.192052.744681.01
Depreciation285.36297.20254.58243.26415.26488.00
Profit Before Tax3163.582358.452456.961615.931637.484193.01
Tax746.82627.37598.08412.16379.701043.34
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.96-15.71-95.26-23.34-196.9336.76
Reported Net Profit2414.801746.791954.141227.111454.713112.91
Extraordinary Items -11.935.483.289.94-81.27-0.13
Adjusted Net Profit2426.731741.311950.861217.171535.983113.04
Adjustment below Net Profit 1.08-5.26-1.698.281.69-6.42
P & L Balance brought forward20090.4018348.8716660.0815864.1414671.4111799.30
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 232.300.00263.66439.45263.67234.38
P & L Balance carried down22273.9820090.4018348.8716660.0815864.1414671.41
Dividend232.300.00263.66439.450.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %400.000.00450.00750.00900.00400.00
Dividend Per Share(Rs)4.000.004.507.509.004.00
Earnings Per Share-Unit Curr41.5830.0833.3520.9424.8353.13
Earnings Per Share(Adj)-Unit Curr41.5830.0833.3520.9424.8353.13
Book Value-Unit Curr391.14353.55336.62307.80292.15271.80
Book Value(Adj)-Unit Curr391.14353.55336.62307.80292.15271.80
Spacer